Biomarker-supported detection of paroxysmal atrial fibrillation in patients with cerebral ischemia.

A longitudinal cohort study in patients presenting with acute cerebral ischemia to identify factors that are predictive individually or in combination for a diagnosis of atrial fibrillation during 12 months of follow-up.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN46104198

Enrollment

300

Registered

2010-02-17

Start date

2009-03-01

Completion date

Unknown

Last updated

2019-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral ischemia, Atrial fibrillation Circulatory System Atrial fibrillation and flutter

Interventions

Serial biomarker sampling for the identification of novel biomarkers to be used in the diagnosis of atrial fibrillation. Blood samples will be collected at 0, 6 and 12 hours after pres

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Cerebral ischemia, i.e. transient ischemic attack (TIA) or stroke 2. Ability and willingness to consent 3. Age > 18 years

Exclusion criteria

Exclusion criteria: 1. Inability or unwillingness to consent 2. Age < 18 years 3. Cerebral haemorrhage

Design outcomes

Primary

Measure	Time frame
Diagnosis of atrial fibrillation from baseline up to 12 months follow-up	—

Secondary

Measure	Time frame
Major adverse cerebral or cardiovascular events (MACCE)	—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 24, 2026